Xenter
Draper, US · Founded 2020 · Delaware corporation · 1 known investors
Xenter develops wireless medical technologies and a medical intelligence platform that aggregates devices, medical data, and diagnostics to apply AI in medicine, with expertise in medical devices and interventional cardiology. The company operates from Salt Lake City with a global network.
Founders & leadership
Xenter was founded in 2020 by Richard J. Linder.
RJ
Richard J. LinderinChairman & CEO
JT
James TobinNamed on SEC filing
EP
Eric PearsonNamed on SEC filing
MS
Mark StautbergNamed on SEC filing
RB
Robert BaxterNamed on SEC filing
RL
Robert LangerNamed on SEC filing
EE
Elazer EdelmanNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$23.5M disclosed across 3 rounds · 2020–2022
▶$19.6MraisedJan 2023 · 79 investors · BiotechnologyRule 506(b)
▶$19.6MraisedJan 2023 · 79 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- James TobinDirector
- Eric PearsonExecutive Officer
- Mark StautbergDirector
- Robert BaxterExecutive Officer, Director
- Robert LangerDirector
- Richard LinderExecutive Officer, Director
- Elazer EdelmanDirector
- Offering amount
- $20M
- Amount sold
- $19.6M
- Minimum investment
- $100K
- Proceeds to insiders
- $1.1M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$1.1MraisedJan 2023 · 12 investors · BiotechnologyRule 506(b)
▶$1.1MraisedJan 2023 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JAMES TOBINDirector
- ROBERT LANGERDirector
- ELAZER EDELMANDirector
- RICHARD LINDERExecutive Officer, Director
- MARK STAUTBERGDirector
- ERIC PEARSONExecutive Officer
- ROBERT BAXTERExecutive Officer, Director
- Offering amount
- $40M
- Amount sold
- $1.1M
- Minimum investment
- $100K
- Proceeds to insiders
- $1.2M
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.8MraisedJan 2021 · 22 investors · Other Health CareRule 506(b)
▶$2.8MraisedJan 2021 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard LinderExecutive Officer, Director
- Robert BaxterDirector
- David SampsonExecutive Officer
- Offering amount
- $12M
- Amount sold
- $2.8M
- Minimum investment
- $100K
- Proceeds to insiders
- $532.5K
- First sale
- Dec 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Enter Health4 shared keywordsENTER provides healthcare payment solutions that help medical providers accelerate revenue collection and increase earnings through revenue cycle management and patient collections services.
Smarter Technologies3 shared keywordsSmarter Technologies is an AI-powered revenue cycle management and automation platform for hospitals and health systems, combining clinical AI agents, human-in-the-loop workflows, and financial and administrative services. Its SmarterNotes product integrates AI-generated clinical documentation with concurrent revenue cycle intelligence to improve documentation accuracy and reimbursement.
Companies competing with Xenter for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Xenter do?
- Xenter develops wireless medical technologies and a medical intelligence platform that aggregates devices, medical data, and diagnostics to apply AI in medicine, with expertise in medical devices and interventional cardiology. The company operates from Salt Lake City with a global network.
- Who founded Xenter?
- Xenter was founded by Richard J. Linder in 2020.
- Who are Xenter's investors?
- Xenter's investors include Black Mountain Investment Group.
- How much funding has Xenter raised?
- Xenter has disclosed $23.5M raised across 3 rounds.
- Where is Xenter headquartered?
- Xenter is headquartered in Draper, US.